Project Grant HT94252310691
Award Date 9/1/23
Completion Date 8/31/25
Dollars Obligated $250K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
- This federal Project Grant award, totaling $249,823.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) and awarded to the University of Manitoba. The grant supports advanced biomedical research aimed at "transforming healthcare for military service members, veterans, and the broader public" through a research project titled "Polygenicity of Brain and Physical Reserve in Multiple Sclerosis." The multi-year...
- The Department of the Army Medical Command awarded a $183,711 Project Grant to Dalhousie University through the Military Medical Research and Development program (CFDA 12.420). The grant supports research into intranasal nanoparticle drug delivery to promote functional recovery in multiple sclerosis. The Military Medical Research and Development program aims to transform military and public health care through innovative biomedical research, including investigating medical solutions for...
- The Defense Health Agency awarded a $999,540.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Governing Council of the University of Toronto, operating as the University of Toronto, to examine the link between hippocampal pathology and meningeal inflammation in progressive multiple sclerosis. The research project is scheduled to be completed by Aug 31, 2026. As a leading public research university, the University of Toronto has a history of...
- This $485,597.91 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research at the Universite De Sherbrooke in Canada. The award will fund a 3-year project from August 1, 2024 to July 31, 2027 focused on understanding the "CONTRIBUTION OF ALTERNATIVE SPLICING TO NEUROFIBROMAGENESIS." The research aims to advance scientific knowledge in the area of neurological disorders, which...
- This federal Project Grant award of $249,612 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The award has a performance period from September 1, 2025 to August 31, 2027 and aims to advance the scientific understanding of the underlying mechanisms of MS through innovative biomedical...
- This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
- The $1,050,767 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University Health Network (UHN) to investigate therapeutic targeting of genomic instability in triple negative breast cancer. The research will be conducted at UHN's location in Ottawa, Ontario over a 3-year period from September 2023 to September 2026. This funding supports UHN's ongoing biomedical and clinical research...
- The U.S. Defense Health Agency has awarded a $999,566 Project Grant to The Cleveland Clinic Foundation for the program titled "Military Medical Research and Development" (CFDA 12.420). The grant supports magnetic resonance imaging-guided transcriptomic analysis of spinal cord neurodegeneration and demyelination in multiple sclerosis. The 3-year project, running from November 1, 2025 to October 31, 2028, will leverage the Cleveland Clinic's expertise in areas such as neuroscience,...
- This $993,283 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco on September 1, 2025. The grant will support a 2-year research project titled "Proteomic Determinants and Components of Progression in Multiple Sclerosis" to be conducted in San Francisco, CA. The project aims to advance biomedical research that can transform healthcare for military...
- The Defense Health Agency awarded a $1,397,266 project grant to The University of Queensland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2023 through February 28, 2026 to develop peptide inhibitors targeting sodium channels for the treatment of Amyotrophic Lateral Sclerosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...